More clinical evidence can be found on the role of GLP1R agonists such as exenatide can improve vascular endothelial dysfunction in diabetic patients, as has been found in this clinical trial by Hu et al., results suggested that exenatide improved the endothelial dysfunction reflected by digital reactive hyperemia index in newly diagnosed patients with T2DM, and the effect was not inferior to single metformin [59]
This metabolic change is likely linked to the chronic inflammation characteristic of RA, creating a potential cycle where inflammation and metabolic issues feed into each other
Liraglutide, a once daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)
At home, I make eggs with some kind of meat or protein
An efficient biological system (or a well-formulated supplement) uses the enzyme glutathione reductase to convert GSSG back into GSH, creating a continuous cycle of protection that maintains a healthy redox balance
Its worth noting that results might take a few weeks